AM
Overview
Ambrish Mithal is a metabolic bone disease specialist at Endocrinology (Member). Has been published in Lancet Diabetes Endocrinol. Based in Global.
Biography
Specialist in Metabolic bone disease at Endocrinology.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Published In
MetabolismDiabetes CareArch OsteoporosLancet Diabetes EndocrinolJ Endocrinol
Key Publications
Best practice recommendations for the diagnosis and management of hypoparathyroidism.
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial).
The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults.
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
The role of glucagon-like peptides in osteosarcopenia.
Areas of Expertise
Medical Specialties
Are you Ambrish Mithal?
Claim your MDRPedia profile to unlock analytics, manage your digital legacy, and receive your verified badge.